Garland J. Scott

Insider profile

Garland J. Scott's trades of Enliven Therapeutics, Inc.'s stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
242.53
Quantity 81,610
Value US$4,268,460
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-10-05 2026-10-01 S Sale
30,496 +34.3%
140.78
US$1,967,061
30,496 +34.3% 140.78 US$1,967,061
2026-10-01 2026-10-01 PrS Proposed sale
81,610
242.53
US$4,268,460
81,610 242.53 US$4,268,460